Jennison Associates Portfolio holdings
Jennison Associates, founded in 1969 and headquartered in New York City, is a global investment management firm managing over $194 billion in assets as of late 2024, specializing in active equity and fixed-income strategies. A subsidiary of PGIM, the asset management arm of Prudential Financial, Jennison serves a diverse client base—including institutions, sub-advisory clients, public plans, endowments, and corporations—with a focus on fundamental research, bottom-up portfolio construction, and high-conviction investing. Known for its equity expertise across styles, geographies, and market capitalizations, as well as investment-grade fixed-income offerings, the firm employs seasoned portfolio managers averaging 29 years of industry experience and 16 years with Jennison. With additional offices in Boston and a culture emphasizing intellectual rigor and long-term client outcomes, Jennison has built a reputation for excellence and stability in the investment management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
S&P Global
SPGI
|
+$677M |
| 2 |
AGN
Allergan plc
AGN
|
+$437M |
| 3 |
Qualcomm
QCOM
|
+$387M |
| 4 |
lululemon athletica
LULU
|
+$366M |
| 5 |
NVIDIA
NVDA
|
+$330M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Under Armour
UAA
|
+$1.03B |
| 2 |
Abbott
ABT
|
+$767M |
| 3 |
MHFI
MCGRAW-HILL FINANCIAL INC COM
MHFI
|
+$627M |
| 4 |
Meta Platforms (Facebook)
META
|
+$520M |
| 5 |
Nike
NKE
|
+$454M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Discretionary | 19.09% |
| 2 | Healthcare | 16.64% |
| 3 | Technology | 14.97% |
| 4 | Communication Services | 12.63% |
| 5 | Financials | 8.79% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
CLR
351
DELISTED
CONTINENTAL RESOURCES INC.
CLR
| $32.4M | 0.04% |
715,764
+6,447
| +0.9% | +$253K |
|
352
Cheniere Energy
CQP
$31.8B
| $32.1M | 0.04% |
1,069,298
+18,886
| +2% | +$551K |
|
353
Rio Tinto
RIO
$148B
| $31.5M | 0.03% |
1,006,795
-47,520
| -5% | -$1.42M |
|
|
NVDQ
354
DELISTED
Novadaq Technologies Inc.
NVDQ
| $30.9M | 0.03% |
3,142,291
-115,508
| -4% | -$1.23M |
|
355
Monolithic Power Systems
MPWR
$65.5B
| $30.9M | 0.03% |
451,721
-63,891
| -12% | -$4.18M |
|
356
Criteo
CRTO
$1.03B
| $30.5M | 0.03% |
+665,024
| New | +$28.6M |
|
|
PINC
357
DELISTED
Premier
PINC
| $30.4M | 0.03% |
929,977
+30,079
| +3% | +$992K |
|
358
Fidelity National Information Services
FIS
$21.5B
| $29.2M | 0.03% |
+396,861
| New | +$27.9M |
|
|
TMH
359
DELISTED
Team Health Holdings Inc
TMH
| $29.2M | 0.03% |
717,546
-389,349
| -35% | -$17M |
|
360
Eldorado Gold
EGO
$8.31B
| $29M | 0.03% |
1,291,870
-61,001
| -5% | -$1.26M |
|
361
Benchmark Electronics
BHE
$2.91B
| $28.9M | 0.03% |
1,367,991
+80,177
| +6% | +$1.68M |
|
362
Prestige Consumer Healthcare
PBH
$2.35B
| $28.7M | 0.03% |
517,774
+132,686
| +34% | +$7.31M |
|
|
JNPR
363
DELISTED
Juniper Networks
JNPR
| $28.6M | 0.03% |
1,272,978
-13,777
| -1% | -$321K |
|
364
B2Gold
BTG
$5.16B
| $28.4M | 0.03% |
11,332,880
-893,254
| -7% | -$1.8M |
|
|
MDCO
365
DELISTED
Medicines Co
MDCO
| $28.4M | 0.03% |
843,072
-148,536
| -15% | -$5.24M |
|
|
FOLD
366
DELISTED
Amicus Therapeutics
FOLD
| $28.1M | 0.03% |
5,147,214
+6,168
| +0.1% | +$43.1K |
|
|
AXE
367
DELISTED
Anixter International Inc
AXE
| $27.8M | 0.03% |
522,215
-77,278
| -13% | -$4.43M |
|
368
Moelis & Co
MC
$4.98B
| $27.8M | 0.03% |
1,235,914
-462,976
| -27% | -$12.4M |
|
|
GPOR
369
DELISTED
Gulfport Energy Corp.
GPOR
| $26.8M | 0.03% |
858,872
-39,697
| -4% | -$1.2M |
|
|
GNMK
370
DELISTED
GenMark Diagnostics, Inc
GNMK
| $26.6M | 0.03% |
3,053,740
-170,854
| -5% | -$1.17M |
|
371
RPC Inc
RES
$1.24B
| $26.4M | 0.03% |
1,697,177
-137,196
| -7% | -$2.01M |
|
|
PFPT
372
DELISTED
Proofpoint, Inc.
PFPT
| $26.3M | 0.03% |
416,474
-22,634
| -5% | -$1.29M |
|
373
AstraZeneca
AZN
$263B
| $25.8M | 0.03% |
427,596
-1,089,872
| -72% | -$63.3M |
|
374
Cadence Design Systems
CDNS
$90B
| $25.8M | 0.03% |
1,061,672
-626,554
| -37% | -$15M |
|
375
Dorman Products
DORM
$4.01B
| $25.7M | 0.03% |
448,969
+129,149
| +40% | +$6.94M |
|
Similar funds
Jennison Associates's Q2 2016 Portfolio in Review
As of Q2 2016, Jennison Associates held 691 positions worth $91.1B, down 4.3% from $95.3B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Jennison Associates withdrew a net $4.67B in Q2 2016, closing 61 positions and reducing 333 holdings. Its most notable exit was MCGRAW-HILL FINANCIAL INC COM, an estimated $627M position sold in full.
By sector, the portfolio is most concentrated in Consumer Discretionary at 19% of assets, down from 20% a quarter earlier, followed by Healthcare and Technology.
Against the trend, Jennison Associates opened a new position in S&P Global worth $677M.
- Jennison Associates's largest Q2 2016 buy was S&P Global: 6,307,763 shares worth $677M.
- Jennison Associates added most to Allergan plc in Q2 2016, an estimated $437M increase.
- Jennison Associates's biggest Q2 2016 reduction was Under Armour, cutting an estimated $1.03B.
- Jennison Associates fully exited MCGRAW-HILL FINANCIAL INC COM in Q2 2016, selling an estimated $627M.
- Jennison Associates's ten largest holdings make up 23% of its $91.1B portfolio in Q2 2016.
- Jennison Associates opened 83 new positions and closed 61 in Q2 2016.
- Jennison Associates's portfolio value fell 4.3% quarter-over-quarter to $91.1B.
Based on Jennison Associates's 13F filing for Q2 2016, filed 3 Aug 2016.